C

California Neuropsychopharmacology Clinical Research Institute | CNRI Los Angeles, CA

Research site

Location

8309 Telegraph Road, Pico Rivera, California, United States of America

Site insights

Top conditions

Top treatments

Lurasidone

SEP-363856

KarXT

Quetiapine fumarate

Seroquel

Lithium

XEN1101

Aripiprazole

Lurasidone HCl

moxifloxacin

Parent organization

This site is a part of California Neuropsychopharmacology Clinical Research Institute

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

CNRI Los Angeles

Verified by this site

Active trials

3 of 21 total trials

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

ML-007C-MA-212 is a 52-week open-label study designed to evaluate the long-term safety, tolerability, and effectiveness of ML-007C-MA in participants...

Enrolling

Schizophrenia

Drug: ML-007C-MA

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

This study will evaluate the long-term safety and tolerability of NBI-1065845 as an adjunctive treatment in participants with MDD.

Enrolling

Major Depressive Disorder

Drug: NBI-1065845

Randomized Withdrawal Study in Patients With Schizophrenia

The purpose of this research is to evaluate the efficacy of dosing iloperidone long-acting injection (LAI) compared to placebo in preventing the exac...

Enrolling

Schizophrenia

Drug: placebo

Drug: iloperidone